6CG2:
reference: Structure-based design and discovery of potent and selective KDM5 inhibitors., Nie Z, Shi L, Lai C, O'Connell SM, Xu J, Stansfield RK, Hosfield DJ, Veal JM, Stafford JA, Bioorg Med Chem Lett. 2018 Mar 30. pii: S0960-894X(18)30288-9. doi:, 10.1016/j.bmcl.2018.03.083. PMID: 29627262

This OCA Structure page
uses Jmol, developed by the Jmol Development Team (documentation).